Xu Y, Shrestha N, Préat V, Beloqui A. Overcoming the intestinal barrier: A look into targeting approaches for improved oral drug delivery systems. J Control Release. 2020;322:486–508. https://doi.org/10.1016/j.jconrel.2020.04.006.

Article  CAS  PubMed  Google Scholar 

Stielow M, Witczyńska A, Kubryń N, Fijałkowski Ł, Nowaczyk J, Nowaczyk A. The Bioavailability of Drugs—The Current State of Knowledge. Molecules. 2023. https://doi.org/10.3390/molecules28248038.

Article  PubMed  PubMed Central  Google Scholar 

Kong X, Lin K, Wu G, Tao X, Zhai X, Lv L, Dong D, Zhu Y, Yang S. Machine Learning Techniques Applied to the Study of Drug Transporters. Molecules. 2023. https://doi.org/10.3390/molecules28165936.

Article  PubMed  PubMed Central  Google Scholar 

Porat D, Dahan A. Active intestinal drug absorption and the solubility-permeability interplay. Int J Pharm. 2018;537:84–93. https://doi.org/10.1016/j.ijpharm.2017.10.058.

Article  CAS  PubMed  Google Scholar 

Nguyen TTL, Duong VA, Maeng HJ. Pharmaceutical formulations with p-glycoprotein inhibitory effect as promising approaches for enhancing oral drug absorption and bioavailability. Pharmaceutics. 2021. https://doi.org/10.3390/pharmaceutics13071103.

Article  PubMed  PubMed Central  Google Scholar 

Husain A, Makadia V, Valicherla GR, Riyazuddin M, Gayen JR. Approaches to minimize the effects of P-glycoprotein in drug transport: A review. Drug Dev Res. 2022;83:825–41. https://doi.org/10.1002/ddr.21918.

Article  CAS  PubMed  Google Scholar 

Mohana S, Ganesan M, Agilan B, Karthikeyan R, Srithar G, Beaulah Mary R, Ananthakrishnan D, Velmurugan D, Rajendra Prasad N, Ambudkar SV. Screening dietary flavonoids for the reversal of P-glycoprotein-mediated multidrug resistance in cancer. Mol Biosyst. 2016;12:2458–70. https://doi.org/10.1039/c6mb00187d.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Das V, Pinto D, Hariharan T, Banerjee T, Ubale R, Up-Palapati A, Renganathan G A Comprehensive Modeling of Bioenhancers Docked to Transport Proteins to Enhance Bioavailability. https://doi.org/10.47611/jsrhs.v11i4.3727

Teja A, Musmade PB, Khade AB, Dengale SJ. Simultaneous improvement of solubility and permeability by fabricating binary glassy materials of Talinolol with Naringin: Solid state characterization, in-vivo in-situ evaluation. Eur J Pharm Sci. 2015;78:234–44. https://doi.org/10.1016/j.ejps.2015.08.002.

Article  CAS  PubMed  Google Scholar 

Uppala S, Vullendula SKA, Yarlagadda DL, Dengale SJ. Exploring the utility of co-amorphous materials to concurrently improve the solubility and permeability of Fexofenadine. J Drug Deliv Sci Technol. 2022. https://doi.org/10.1016/j.jddst.2022.103431.

Article  Google Scholar 

Gurunath S, Nanjwade BK, Patil PA. Oral bioavailability and intestinal absorption of candesartan cilexetil: Role of naringin as P-glycoprotein inhibitor. Drug Dev Ind Pharm. 2015;41:170–6. https://doi.org/10.3109/03639045.2013.850716.

Article  CAS  PubMed  Google Scholar 

Shi HF, Zhao FL, Chen H, et al. Naringenin has an inhibitory effect on rivaroxaban in rats both in vitro and in vivo. Pharmacol Res Perspect. 2021. https://doi.org/10.1002/prp2.782.

Article  PubMed  PubMed Central  Google Scholar 

Alotaibi F. Naringenin alters the pharmacokinetics of ranolazine in part through the inhibition of cytochrome P450 (3A4) and P-glycoprotein. Futur J Pharm Sci. 2023. https://doi.org/10.1186/s43094-023-00477-1.

Article  Google Scholar 

Nair A, Varma R, Gourishetti K, Bhat K, Dengale S. Influence of Preparation Methods on Physicochemical and Pharmacokinetic Properties of Co-amorphous Formulations: The Case of Co-amorphous Atorvastatin: Naringin. J Pharm Innov. 2020;15:365–79. https://doi.org/10.1007/s12247-019-09381-9.

Article  Google Scholar 

Bhutto ZA, He F, Zloh M, Yang J, Huang J, Guo T, Wang L. Use of quercetin in animal feed: Effects on the P-gp expression and pharmacokinetics of orally administrated enrofloxacin in chicken. Sci Rep. 2018. https://doi.org/10.1038/s41598-018-22354-1.

Article  PubMed  PubMed Central  Google Scholar 

Dengale SJ, Hussen SS, Krishna BSM, Musmade PB, Gautham Shenoy G, Bhat K. Fabrication, solid state characterization and bioavailability assessment of stable binary amorphous phases of Ritonavir with Quercetin. Eur J Pharm Biopharm. 2015;89:329–38. https://doi.org/10.1016/j.ejpb.2014.12.025.

Article  CAS  PubMed  Google Scholar 

Wang X, Chen Y, Dahmani FZ, Yin L, Zhou J, Yao J. Amphiphilic carboxymethyl chitosan-quercetin conjugate with P-gp inhibitory properties for oral delivery of paclitaxel. Biomaterials. 2014;35:7654–65. https://doi.org/10.1016/j.biomaterials.2014.05.053.

Article  CAS  PubMed  Google Scholar 

Yu J, Chen H, Jiang L, Wang J, Dai J, Wang J. Codelivery of Adriamycin and P-gp Inhibitor Quercetin Using PEGylated Liposomes to Overcome Cancer Drug Resistance. J Pharm Sci. 2019;108:1788–99. https://doi.org/10.1016/j.xphs.2018.12.016.

Article  CAS  PubMed  Google Scholar 

Han J, Yang Y, Hou Y, Tang M, Zhang Y, Zhu Y, Liu X, Wang J, Gao Y. Insight into Formation, Synchronized Release and Stability of Co-Amorphous Curcumin-Piperine by Integrating Experimental-Modeling Techniques. J Pharm Sci. 2024;113:1874–84. https://doi.org/10.1016/j.xphs.2024.02.009.

Article  CAS  PubMed  Google Scholar 

Han J, Wei Y, Li L, Song Y, Pang Z, Qian S, Zhang J, Gao Y, Heng W. Gelation Elimination and Crystallization Inhibition by Co-Amorphous Strategy for Amorphous Curcumin. J Pharm Sci. 2023;112:182–94. https://doi.org/10.1016/j.xphs.2022.07.014.

Article  CAS  PubMed  Google Scholar 

Bhagwat A, Pathan IB, Chishti NAH. Design and optimization of pellets formulation containing curcumin ascorbic acid co-amorphous mixture for ulcerative colitis management. Part Sci Technol. 2021;39:859–67. https://doi.org/10.1080/02726351.2020.1848946.

Article  CAS  Google Scholar 

Dubey T, Sonawane SK, Mannava MC, Nangia AK, Chandrashekar M, Chinnathambi S. The inhibitory effect of Curcumin-Artemisinin co-amorphous on Tau aggregation and Tau phosphorylation. Colloids Surf B Biointerfaces. 2023. https://doi.org/10.1016/j.colsurfb.2022.112970.

Article  PubMed  Google Scholar 

Skieneh JM, Sathisaran I, Dalvi SV, Rohani S. Co-amorphous form of curcumin-folic acid dihydrate with increased dissolution rate. Cryst Growth Des. 2017;17:6273–80. https://doi.org/10.1021/acs.cgd.7b00947.

Article  CAS  Google Scholar 

Feng Y, Li B, Yang L, Liu Y. Co-amorphous delivery systems based on curcumin and hydroxycinnamic acids: Stabilization, solubilization, and controlled release. LWT. 2022. https://doi.org/10.1016/j.lwt.2022.114091.

Article  Google Scholar 

Han J, Li L, Su M, Heng W, Wei Y, Gao Y, Qian S. Deaggregation and crystallization inhibition by small amount of polymer addition for a co-amorphous curcumin-magnolol system. Pharmaceutics. 2021. https://doi.org/10.3390/pharmaceutics13101725.

Article  PubMed  PubMed Central  Google Scholar 

Patil U, Rawal S, Pantwalawalkar J, Nangare S, Dagade D, Patil P, Jadhav NR. Development of amino acid salt-based curcumin@ lysine acetate co-amorphous system using liquid-assisted grinding for improved solubility and dissolution. The Thai Journal of Pharmaceutical Sciences. 2023;46(6):711–9.

Google Scholar 

Mancillas-Quiroz JA, Carrasco-Portugal M del C, Mondragón-Vásquez K, Huerta-Cruz JC, Rodríguez-Silverio J, Rodríguez-Vera L, Reyes-García JG, Flores-Murrieta FJ, Domínguez-Chávez JG, Rocha-González HI (2025) Development of a Novel Co-Amorphous Curcumin and L-Arginine (1:2): Structural Characterization, Biological Activity and Pharmacokinetics. Pharmaceutics. https://doi.org/10.3390/pharmaceutics17010011

Saganowska P, Wesolowski M. DSC as a screening tool for rapid co-crystal detection in binary mixtures of benzodiazepines with co-formers. J Therm Anal Calorim. 2018;133:785–95. https://doi.org/10.1007/s10973-017-6858-3.

Article  CAS  Google Scholar 

Shah I, Vyas J. Role of P-gp inhibitors on gut permeation of metformin: an ex-vivo study. Int J Pharm Pharm Sci. 2022;14(10):18–23. https://doi.org/10.22159/ijpps.2022v14i10.45135

Kim Y, Chen J. Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation. Science. 2018;359(6378):915–9. https://doi.org/10.1126/science.aar7389.

Article  CAS  PubMed  Google Scholar 

Desai MP, Harish Patil P, Vullendula SKA, Birangal S, Shenoy GG, Rao M, Dengale SJ, Bhat K, Channabasavaiah JP. Molecular Insights into the Mechanism of Modulatory Effects of Proton Pump Inhibitors on P-glycoprotein Mediated Drug Transport of Palbociclib and Ribociclib. Curr Drug Metab. 2023;24:458–65. https://doi.org/10.2174/1389200224666230815122312.

Article  CAS  PubMed